Featured Speakers

  • Francis LeeDirector, Tumor Pharmacology and Experimental Therapeutics Bristol-Myers Squibb

  • Hui GaoResearch Investigator III, Oncology Pharmacology Novartis

  • Deepak SampathSenior Scientist, Translational Oncology, Genentech

  • Corinne ReimerAssociate Director, In Vivo Pharmacology, Oncology iMed Science Unit AstraZeneca

Why Attend Tumor Models Boston 2014?

The 3rd Annual Tumor Models Boston is a premier networking, interactive and solution-led conference to assist pre-clinical oncologists and tumor model developers to make more clinically relevant predictions and improve the translational success of candidates into human clinical trials.

This is a meeting where attendees discover industry defining information, effective preclinical strategies and expand their network to achieve effective analysis and interpretation of data derived from tumour models. 

Attend and you will:

  • Learn how to run large scale preclinical phase II-like studies with tumor models that better represent the patient population
  • Discover how emerging personalized mouse avatars and co-clinical trials will de-risk later stage clinical development
  • Harness patient derived xenograft (PDX) models to optimize biomarker identification, stratify patient populations and improve translational decision making 
  • Explore novel pharmaco-imaging technology with improved resolution to validate and prioritize drug candidates
  • Learn how RNA Seq technology can allow you to make the connection between preclinical models and clinical outcomes
  • Harness in silico modeling and simulation to translate preclinical data into the design of human clinical trials
  • Discover the technological and logistical advances in tumor models that can increase the translatability of your preclinical studies
  • Learn how to overcome the challenge of tumor heterogeneity through accurate biological modeling
  • Discover how to target the tumor microenvironment with models that identify cancer initiation, progression and resistance mechanisms
  • Understand the clinician’s perspective on tumor model data and improve cross-collaboration for more cost-effective drug development

What Next and How Do I Get Involved?

  1. Download the brochure to see the full agenda and speaker line up
  2. If you have any material you would like to share, present or discuss, let us know as we have opportunites to speak or sponsor
  3. If you're planning on joining us this year, book before June 20th and save up to $200. Book online, call +44 (0)203 141 8700 or email to register

Don't miss our London event: